Pancreatic cancer ascites xenograft–an expeditious model mirroring advanced therapeutic resistant disease

Pancreatic ductal adenocarcinoma has limited treatment options. There is an urgent need for developing appropriate pre-clinical models recapitulating metastatic disease, the most common clinical scenario at presentation. Ascites accumulation occurs in up to 20–30% of patients with pancreatic cancer;...

Descripción completa

Detalles Bibliográficos
Autores principales: Golan, Talia, Stossel, Chani, Schvimer, Michael, Atias, Dikla, Halperin, Sharon, Buzhor, Ella, Raitses-Gurevich, Maria, Cohen, Keren, Pri-Chen, Sara, Wilson, Julie, Denroche, Robert E., Lungu, Ilinca, Bartlett, John M.S., Mbabaali, Faridah, Yarden, Yosef, Nataraj, Nishanth Belugali, Gallinger, Steven, Berger, Raanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522335/
https://www.ncbi.nlm.nih.gov/pubmed/28489577
http://dx.doi.org/10.18632/oncotarget.17253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522335/
https://www.ncbi.nlm.nih.gov/pubmed/28489577
http://dx.doi.org/10.18632/oncotarget.17253

Ejemplares similares